A University of Missouri study has disproven a long-held theory about the nervous system's development, identifying key proteins involved in the process. The findings shed light on how neurofilaments affect axonal diameters and could lead to a better understanding of neurological diseases such as multiple sclerosis.
Researchers identified an essential protein that plays a key role in myelination and remyelination, processes vital for healthy brain development and repair. The discovery has major implications for treating brain damage in newborns and may lead to treatments or interventions to enhance brain health.
Researchers propose a new mechanism for Alzheimer's disease, linking breakdown of myelin to amyloid-beta fibrils and neurodegeneration. Myelination is key to brain function, and its decline with age may underlie the disease's progression.
Researchers discovered that astrocytes promote myelination by releasing leukemia inhibitory factor (LIF) in response to electrical impulses. This finding may lead to new treatments for demyelinating diseases, such as multiple sclerosis.
Research suggests that disruption of myelination is a key component behind childhood developmental disorders such as autism, ADHD, and schizophrenia. Incomplete inhibitory circuits may lead to impulsive behaviors, while fully functional excitatory circuits worsen psychiatric disorders.
Researchers used DTI to study adolescents with early-onset schizophrenia and found distinct differences in white brain matter of the frontal lobe. This disruption can lead to developmental abnormalities and abnormal behaviors.
Rats' brain composition changes until 180 days of age, with axon myelination increasing and visual information transfer between hemispheres potentially improving. The study challenges previous beliefs about brain growth and offers insights into potential neurological disorders.